SCHEMBL5080717

SCHEMBL5080717

O=CC(Cl)c1cccc(F)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
CES2 O00748 2/20 0.43
CES1 P23141 2/20 0.43
IDO1 P14902 1/20 0.41
TDO2 P48775 1/20 0.41
NFE2L2 Q16236 2/20 0.39
CNR2 P34972 1/20 0.37
FAAH O00519 1/20 0.36
MGLL Q99685 1/20 0.36
AOC3 Q16853 1/20 0.36
ACHE P22303 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
PKM P14618 1/20 0.35
MAPK1 P28482 1/20 0.35
THPO P40225 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7917545 0.79 HDAC4 (0.47) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL2562362 0.79 HDAC4 (0.47) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL5073765 0.79 CES2 (0.38) CES2CES1IDO1TDO2
SCHEMBL4598932 0.78 ACP3 (0.44) MGLLAOC3CYP1A2
SCHEMBL3712912 0.76 TSHR (0.48) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL5520949 0.76 HDAC4 (0.47) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL11279836 0.76 CES2 (0.51) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL167914 0.76 HDAC4 (0.44) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL1723875 0.76 ESR1 (0.44) CYP3A4
SCHEMBL16794983 0.76 FAAH (0.36) FAAHMGLLCYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904477-A1 INDOL-3-CARBONYL-SPIRO-PIPERIDINE DERIVATIVES AS V1A RECEPTOR ANTAGONISTS F. Hoffmann-Roche AG (CH) 2008-04-02 EP disclosed
WO-2007006688-A1 INDOL-3-CARBONYL-SPIRO-PIPERIDINE DERIVATIVES AS V1A RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2007-01-18 WO disclosed